Safety, tolerability, pharmacokinetics and pharmacodynamics of the oral cyclin-dependent kinase inhibitor AZD5438 when administered at intermittent and continuous dosing schedules in patients with advanced solid tumours
Titel:
Safety, tolerability, pharmacokinetics and pharmacodynamics of the oral cyclin-dependent kinase inhibitor AZD5438 when administered at intermittent and continuous dosing schedules in patients with advanced solid tumours
Auteur:
Boss, D.S. Schwartz, G.K. Middleton, M.R. Amakye, D.D. Swaisland, H. Midgley, R.S. Ranson, M. Danson, S. Calvert, H. Plummer, R. Morris, C. Carvajal, R.D. Chirieac, L.R. Schellens, J.H.M. Shapiro, G.I.